ACADIA Pharmaceuticals(ACAD)
$18.32-0.35 (-1.87%)
ACAD
ACADIA Pharmaceuticals earnings date
$18.32
At close:-0.35 (-1.87%)
Want to see ACAD full AI Analyst Report?
ACADIA Pharmaceuticals (ACAD) Q2 2022 Earnings Report
2,463 Followers
ACAD Q2 2022 EPS Results
- Actual EPS
- -$0.21
- Consensus EPS
- -$0.25
- Beat/Miss
- Beat by +$0.04
- One Year Ago EPS
- -$0.27
ACAD Q2 2022 Revenue Results
- Actual Revenue
- $134.56M
- Expected Revenue
- $130.41M
- Beat/Miss
- Beat by +$4.16M
- YoY Revenue Growth
- +16.79%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/08/2022
- Time
- After Close
- Conference Call
- Monday, August 8, 2022
ACAD Upcoming Earnings
ACADIA Pharmaceuticals's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
ACAD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | 0.27- | 1.6 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 0.200.31 | 0.42 | -26.19% (-0.11) | |
| Aug 04, 2026 | 2026 (Q2) | 0.070.18 | 0.16 | 12.50% (+0.02) | |
| May 06, 2026 | 2026 (Q1) | 0.050.02 | 0.11 | -81.82% (-0.09) | |
| Feb 25, 2026 | 2025 (Q4) | 0.141.60 | 0.86 | 86.05% (+0.74) | |
| Nov 05, 2025 | 2025 (Q3) | 0.170.42 | 0.2 | 110.00% (+0.22) | |
| Aug 06, 2025 | 2025 (Q2) | 0.140.16 | 0.2 | -20.00% (-0.04) | |
| May 07, 2025 | 2025 (Q1) | 0.090.11 | 0.1 | 10.00% (+0.01) | |
| Feb 26, 2025 | 2024 (Q4) | 0.220.86 | 0.28 | 207.14% (+0.58) | |
| Nov 06, 2024 | 2024 (Q3) | 0.140.20 | -0.4 | 150.00% (+0.60) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

